In 2023, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved 891 Investigational New Drug (IND) applications of biopharmaceuticals. Almost 54 percent of all approved IND applications were ones concerning antineoplastic drugs.
Distribution of therapeutic areas for approved biopharmaceutical Investigational New Drug (IND) applications in China in 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (February 4, 2024). Distribution of therapeutic areas for approved biopharmaceutical Investigational New Drug (IND) applications in China in 2023 [Graph]. In Statista. Retrieved October 06, 2024, from https://www.statista.com/statistics/1320129/china-therapeutic-for-approved-biopharmaceutical-ind-applications/
National Medical Products Administration. "Distribution of therapeutic areas for approved biopharmaceutical Investigational New Drug (IND) applications in China in 2023." Chart. February 4, 2024. Statista. Accessed October 06, 2024. https://www.statista.com/statistics/1320129/china-therapeutic-for-approved-biopharmaceutical-ind-applications/
National Medical Products Administration. (2024). Distribution of therapeutic areas for approved biopharmaceutical Investigational New Drug (IND) applications in China in 2023. Statista. Statista Inc.. Accessed: October 06, 2024. https://www.statista.com/statistics/1320129/china-therapeutic-for-approved-biopharmaceutical-ind-applications/
National Medical Products Administration. "Distribution of Therapeutic Areas for Approved Biopharmaceutical Investigational New Drug (Ind) Applications in China in 2023." Statista, Statista Inc., 4 Feb 2024, https://www.statista.com/statistics/1320129/china-therapeutic-for-approved-biopharmaceutical-ind-applications/
National Medical Products Administration, Distribution of therapeutic areas for approved biopharmaceutical Investigational New Drug (IND) applications in China in 2023 Statista, https://www.statista.com/statistics/1320129/china-therapeutic-for-approved-biopharmaceutical-ind-applications/ (last visited October 06, 2024)
Distribution of therapeutic areas for approved biopharmaceutical Investigational New Drug (IND) applications in China in 2023 [Graph], National Medical Products Administration, February 4, 2024. [Online]. Available: https://www.statista.com/statistics/1320129/china-therapeutic-for-approved-biopharmaceutical-ind-applications/